Gullberg & Jansson redovisade minskad nettoomsättning och ökad EBIT i det andra kvartalet.
- H1 delivered in line - All eyes on the autumn intake - Fair value range of NOK 14-25 H1 delivered ...
Redeye comments on Faron’s announcement that it has reached alignment with the FDA on the registrati...
Net sales was 2% above our expectation but adjusted EBITDA came 6% below our forecast in Q2.
Redeye takes a positive view of the divestment of Public, making Formpipe a clear and scalable SaaS ...
Aspo’s EUR 9.2m comparable EBITA fell some EUR 1m short of the estimates; in our view this was due t...
Redeye updates on EG7 after weaker-than-expected Q2-results, where a solid performance of Palia was ...
Redeye updates its view on Verve Group following its Q2 2025 report, which was weaker than expected.
Redeye notes Safello’s headwinds from Q1 continued into Q2 2025, with net sales disappointing, resul...
Redeye initiates coverage of Relais Group, an emerging serial acquirer in the European vehicle after...
Aspo sells its Leipurin business for EV value of EUR 63m.
- Q2 sales SEK 15m, EBIT -16m, in line with profit warning - OEM business to rebound, anticipate str...
- Figures in line with pre-announcement - Aurdel a little softer than expected - Consensus EBIT esti...
Redeye state’s Safello’s Q2 2025 presented top-line headwinds with net sales of SEK130.
Administer's Q2 was slightly weaker than expected, with the y/y EBITDA improvement streak coming to ...
